Kyntra Bio, Inc. (KYNB): Net Income
$183.45M
Year ended 2025-12-31
$183.19M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $183.45M | n/m | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | -$47.58M | n/m | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | -$284.23M | n/m | 2025-03-17, From 2023-01-01 |
| 2022-12-31 | -$293.65M | n/m | 2024-02-26, From 2022-01-01 |
| 2021-12-31 | -$290.02M | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$189.29M | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$76.97M | n/m | 2022-03-04, From 2019-01-01 |
| 2018-12-31 | -$86.42M | n/m | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | -$120.88M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$58.07M | n/c | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | -$85.78M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$59.50M | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | -$14.94M | n/a | 2016-02-29, From 2013-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $183.45M | n/m |
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | -$90.97M | n/m |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | -$80.40M | n/m |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | -$57.59M | n/m |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | -$77.74M | n/m |
| Sagimet Biosciences Inc. (SGMT) | 2025-12-31 | -$51.04M | n/m |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | -$78.26M | n/m |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | -$30.52M | n/m |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | -$63.06M | n/m |
Compare KYNB, FLNA, CAMP, AARD side by side · Screen every company in Pharmaceutical Preparations ↗